<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

	<!-- RSS feed defaults -->
	<channel>
		<title>Wyss InstituteToxicology &#8211; Wyss Institute</title>
		<link>https://wyss.harvard.edu</link>
		<description>Wyss Institute at Harvard</description>
		<lastBuildDate>Tue, 05 May 2026 13:55:08 +0000</lastBuildDate>
		<language>en-US</language>
		<sy:updatePeriod>hourly</sy:updatePeriod>
		<sy:updateFrequency>1</sy:updateFrequency>
		<atom:link href="https://wyss.harvard.edu/discipline/toxicology/feed/" rel="self" type="application/rss+xml" />

		<generator>https://wordpress.org/?v=6.7.1</generator>

		<!-- Start loop -->
		
			<item>
				<title>Beating cancer cells at their own game by stepping on their cGAS</title>
				<link>https://wyss.harvard.edu/news/beating-cancer-cells-at-their-own-game-by-stepping-on-their-cgas/</link>
        <pubDate>Wed, 12 Nov 2025 17:30:44 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Research Spotlights]]></category>
		<category><![CDATA[Brigham and Women's Hospital]]></category>
		<category><![CDATA[Gene Expression]]></category>
		<category><![CDATA[Harvard Medical School]]></category>
		<category><![CDATA[Immune System]]></category>
		<category><![CDATA[MIT]]></category>
		<category><![CDATA[Nanoparticles]]></category>
		<category><![CDATA[Natalie Artzi]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=44182</guid>
                            <description>Switching on an immune pathway in cancer cells with a new mRNA therapy reprograms the immune system in complex tumor environments to launch a broader attack</description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON) &mdash; Cancer cells develop various strategies to paralyze immune cells to evade their attack in the complex tumor microenvironment (TME). Using one such strategy, they cripple their own production of a small signaling molecule known as cGAMP, which, if released into the TME, can be taken up by immune cells that then build up a first line of defense against cancer&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/beating-cancer-cells-at-their-own-game-by-stepping-on-their-cgas/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/beating-cancer-cells-at-their-own-game-by-stepping-on-their-cgas/</link>
          <title>Reactivating the immune system in the complex environments of tumors, such as melanoma tumors, is a promising way forward. But not nearly all patients are benefiting from such immunotherapies yet and, often, bigger therapeutic outcomes would be desirable. A new mRNA therapy turns on an immune pathway in cancer cells themselves to put immune cells in the tumor environment into action. Credit: Envato Elements?WBMUL</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2025/11/12101832/dermatologist-examining-mole-with-magnifying-glass-2025-10-28-21-50-31-utc-scaled.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=c500f53bf481ea7dcbf8f595c50baca6"/></url>
				</image>
        			</item>

		
			<item>
				<title>Human Organ Chip technology sets stage for pan-influenza A CRISPR RNA therapies</title>
				<link>https://wyss.harvard.edu/news/human-organ-chip-technology-sets-stage-for-pan-influenza-a-crispr-rna-therapies/</link>
        <pubDate>Wed, 15 Oct 2025 13:55:54 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Biomimetic Microsystems]]></category>
		<category><![CDATA[CRISPR]]></category>
		<category><![CDATA[Donald E. Ingber]]></category>
		<category><![CDATA[Gene Expression]]></category>
		<category><![CDATA[Harvard Medical School]]></category>
		<category><![CDATA[Influenza]]></category>
		<category><![CDATA[Lung-on-a-chip]]></category>
		<category><![CDATA[Nanoparticles]]></category>
		<category><![CDATA[Natalie Artzi]]></category>
		<category><![CDATA[Pathogen]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=43920</guid>
                            <description>Human lung alveolus chip infection model enables investigation of viral replication, inflammatory responses, and genetic off-target effects of a novel pan-influenza CRISPR therapy</description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON) &ndash; The Influenza A virus (IAV) has been the cause of six major flu pandemics, responsible for 50 to 100 million deaths globally. In the U.S. alone, it is estimated that, despite seasonally updated vaccines, IAV infections still lead to 140,000 to 710,000 hospitalizations and 12,000 to 52,000 deaths annually. The development of antiviral treatments against IAV&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/human-organ-chip-technology-sets-stage-for-pan-influenza-a-crispr-rna-therapies/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/human-organ-chip-technology-sets-stage-for-pan-influenza-a-crispr-rna-therapies/</link>
          <title>New findings show that future pan-influenza A vaccines based on CRISPR technology can be preclinically assessed in human Organ Chips. Credit: Envato Elements/dvatri</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2025/10/14105510/portrait-of-a-family-activities-at-home-2025-09-14-16-44-58-utc-scaled.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=c1f3463c4436feb34fe1078d4163cfb9"/></url>
				</image>
        			</item>

		
			<item>
				<title>Wyss Institute at Harvard University launches its Diagnostics for Human and Planetary Health platform headed by David Walt</title>
				<link>https://wyss.harvard.edu/news/wyss-institute-at-harvard-university-launches-its-novel-diagnostics-for-human-and-planetary-health-platform-headed-by-david-walt/</link>
        <pubDate>Mon, 10 Feb 2025 14:55:47 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[David R. Walt]]></category>
		<category><![CDATA[Environment]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=42021</guid>
                            <description>To tackle major diagnostic challenges, the platform will deeply integrate with faculty and technological strengths across the Institute to develop disruptive diagnostic capabilities  </description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON) &mdash; To address the diagnostic challenges of our times and prepare for the future of healthcare, the Wyss Institute is launching its &ldquo;Diagnostics for Human and Planetary Health&rdquo; platform. Patients with a plethora of diseases could be treated more effectively now, if they had access to sensitive diagnostic tests. In addition, many diseases cannot be diagnosed early&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/wyss-institute-at-harvard-university-launches-its-novel-diagnostics-for-human-and-planetary-health-platform-headed-by-david-walt/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/wyss-institute-at-harvard-university-launches-its-novel-diagnostics-for-human-and-planetary-health-platform-headed-by-david-walt/</link>
          <title>Wyss Core Faculty member David Walt is at the helm of the newly founded Diagnostics for Human and Planetary Health platform. Credit: Niles Singer/Harvard University</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2025/01/31084039/091024_Findings_Walt_0178-scaled.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=8cce6bbdfe676b50fa49b807762816e1"/></url>
				</image>
        			</item>

		
			<item>
				<title>14 Wyss Faculty named Highly Cited Researchers in 2022</title>
				<link>https://wyss.harvard.edu/news/14-wyss-faculty-named-highly-cited-researchers-in-2022/</link>
        <pubDate>Wed, 16 Nov 2022 15:57:03 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Awards]]></category>
		<category><![CDATA[Community]]></category>
		<category><![CDATA[Christopher Chen]]></category>
		<category><![CDATA[Conor Walsh]]></category>
		<category><![CDATA[David A. Weitz]]></category>
		<category><![CDATA[David Mooney]]></category>
		<category><![CDATA[Donald E. Ingber]]></category>
		<category><![CDATA[George Church]]></category>
		<category><![CDATA[George Whitesides]]></category>
		<category><![CDATA[James J. Collins]]></category>
		<category><![CDATA[Jennifer A. Lewis]]></category>
		<category><![CDATA[Joanna Aizenberg]]></category>
		<category><![CDATA[Kevin Kit Parker]]></category>
		<category><![CDATA[Peng Yin]]></category>
		<category><![CDATA[Robert Wood]]></category>
		<category><![CDATA[Samir Mitragotri]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=34611</guid>
                            <description>The honor celebrates researchers who have published papers ranking within the top 1% of citations over the last decade</description>
                                        <content:encoded><![CDATA[<p>By Lindsay Brownell (BOSTON) &mdash; Clarivate has announced its Highly Cited Researchers 2022 list, which uses both quantitative and qualitative analysis to identify individuals from across the globe who have demonstrated significant and broad influence in their chosen field(s) of research. Each year&rsquo;s list recognizes the authors of scientific papers that rank in the top 1% by citations in the Web&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/14-wyss-faculty-named-highly-cited-researchers-in-2022/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/14-wyss-faculty-named-highly-cited-researchers-in-2022/</link>
          <title>Clarivate's Highly Cited Researchers list celebrates academic researchers whose papers are in the top 1% of citations globally, indicating broad impact. Credit: Shutterstock/nepool</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2022/11/15134633/shutterstock_676526785.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=18625d10325ee63ad5e3d36858311ab9"/></url>
				</image>
        			</item>

		
			<item>
				<title>A new vision for AAV-delivered gene therapies</title>
				<link>https://wyss.harvard.edu/news/a-new-vision-for-aav-delivered-gene-therapies/</link>
        <pubDate>Wed, 10 Feb 2021 18:58:16 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Adeno-Associated Virus (AAV)]]></category>
		<category><![CDATA[Drug Delivery]]></category>
		<category><![CDATA[Gene Expression]]></category>
		<category><![CDATA[Gene Therapy]]></category>
		<category><![CDATA[George Church]]></category>
		<category><![CDATA[Harvard Medical School]]></category>
		<category><![CDATA[Tissue Regeneration]]></category>
		<category><![CDATA[Virus]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=27373</guid>
                            <description>A broadly applicable AAV genome-coupled immunomodulation strategy helps cloak the AAV virus from unwanted immune responses, and offers important insights into ocular inflammation </description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON) &mdash; In recent years, adeno&#x2d;associated virus (AAV) has been recognized as the leading vehicle (vector) for in vivo delivery of therapeutic genes because it is non&#x2d;pathogenic and efficiently targets many different cell and tissue types. The recent Federal Drug Administration (FDA) approvals of AAV&#x2d;based gene&#x2d;replacement therapies to treat spinal muscular atrophy and a&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/a-new-vision-for-aav-delivered-gene-therapies/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/a-new-vision-for-aav-delivered-gene-therapies/</link>
          <title>ImageJ=1.49v
unit=u00B5m</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2021/02/08165851/AAV-Cloaking_Listing-Image.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=dddac08c05ea554c61fabe4bd25f0618"/></url>
				</image>
        			</item>

		
			<item>
				<title>Interrogator: Human Organ-on-Chips</title>
				<link>https://wyss.harvard.edu/media-post/interrogator-human-organ-on-chips/</link>
        <pubDate>Mon, 27 Jan 2020 16:00:40 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Biomimetic Microsystems]]></category>
		<category><![CDATA[DARPA]]></category>
		<category><![CDATA[Donald E. Ingber]]></category>
		<category><![CDATA[Emulate Inc.]]></category>
		<category><![CDATA[Gut-on-a-Chip]]></category>
		<category><![CDATA[Harvard SEAS]]></category>
		<category><![CDATA[Heart-on-a-Chip]]></category>
		<category><![CDATA[Kevin Kit Parker]]></category>
		<category><![CDATA[Liver-on-a-Chip]]></category>
		<category><![CDATA[Vasculature]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?post_type=media_post&#038;p=23307</guid>
                                                <content:encoded><![CDATA[<p>This video describes the &ldquo;Interrogator&rdquo; instrument that can be programmed to culture up to 10 different Organ Chips and sequentially transfer fluids between their vascular channels to mimic normal human blood flow between the different organs of our body. Its integrated microscope enables the continuous monitoring of the tissues&rsquo; integrities in the individual organ chips in long&#x2d;term studies.</p>
<p><a href="https://wyss.harvard.edu/media-post/interrogator-human-organ-on-chips/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/media-post/interrogator-human-organ-on-chips/</link>
          <title></title>
					<url>https://wyss-prod.imgix.net/app/uploads/2020/01/27105238/THUMBNAIL_Interrogator-Human-Organ-on-Chips_NO-TEXT.png?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=548ed02de09ed64ce127e290548da53f"/></url>
				</image>
        			</item>

		
			<item>
				<title>Human Body-on-Chip platform enables in vitro prediction of drug behaviors in humans</title>
				<link>https://wyss.harvard.edu/news/human-body-on-chip-platform-enables-in-vitro-prediction-of-drug-behaviors-in-humans/</link>
        <pubDate>Mon, 27 Jan 2020 15:58:57 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Research Spotlights]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Biomimetic Microsystems]]></category>
		<category><![CDATA[DARPA]]></category>
		<category><![CDATA[Donald E. Ingber]]></category>
		<category><![CDATA[Emulate Inc.]]></category>
		<category><![CDATA[Gut-on-a-Chip]]></category>
		<category><![CDATA[Harvard SEAS]]></category>
		<category><![CDATA[Heart-on-a-Chip]]></category>
		<category><![CDATA[Kevin Kit Parker]]></category>
		<category><![CDATA[Liver-on-a-Chip]]></category>
		<category><![CDATA[Vasculature]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=23016</guid>
                            <description>Fluidically-linked systems of multiple human Organ Chips that quantitatively predict drug pharmacokinetics may offer alternatives to some animal tests</description>
                                        <content:encoded><![CDATA[<p>(BOSTON) &mdash; Drug development is an extremely arduous and costly process, and failure rates in clinical trials that test new drugs for their safety and efficacy in humans remain very high. According to current estimates, only 13.8% of all tested drugs demonstrate ultimate clinical success and obtain approval by the Food and Drug Administration (FDA). There are also increasing ethical concerns&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/human-body-on-chip-platform-enables-in-vitro-prediction-of-drug-behaviors-in-humans/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/human-body-on-chip-platform-enables-in-vitro-prediction-of-drug-behaviors-in-humans/</link>
          <title>In this graphic, the Wyss Institute’s human Body-on-Chip system is layered on top of Leonardo da Vinci’s ink drawing of the “Vitruvian Man”, which represents ideal human body proportions. The researchers used a computational scaling method to translate data obtained from drug experiments in the human Body-on-Chip to the organ dimensions of the real human body. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2019/12/19121206/LinkedOrganChipsCover-e1608165653559.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=a1c81eecceadaf9857c4c173423b0c7a"/></url>
				</image>
        			</item>

		
			<item>
				<title>FcMBL: Broad-Spectrum Pathogen Capture for Infectious Disease Diagnosis and Therapy</title>
				<link>https://wyss.harvard.edu/technology/fcmbl-broad-spectrum-pathogen-capture-for-infectious-diseases/</link>
        <pubDate>Wed, 11 Sep 2019 00:35:45 +0000</pubDate>
        <dc:creator><![CDATA[admin]]></dc:creator>
        		<category><![CDATA[Blood]]></category>
		<category><![CDATA[COVID-19]]></category>
		<category><![CDATA[Donald E. Ingber]]></category>
		<category><![CDATA[FcMBL]]></category>
		<category><![CDATA[Fungi]]></category>
		<category><![CDATA[Immune System]]></category>
		<category><![CDATA[Pathogen]]></category>
		<category><![CDATA[Protein Engineering]]></category>
		<category><![CDATA[Virus]]></category>
				<guid isPermaLink="false">https://wyss.prod.a17.io/technology/capture-and-concentration-of-microbial-pathogens-fcmbl/</guid>
                            <description><a href="https://boabiomedical.com/" target="blank">BOA Biomedical</a> is developing the Wyss Institute's FcMBL pathogen-capture technology into products that quickly remove pathogens from the body and enable their rapid identification, giving critically ill patients a higher chance of survival. </description>
                                        <content:encoded><![CDATA[<p>Infectious diseases have plagued humanity for millennia, and the pathogens that infect and sicken humans are constantly evolving. Severe infections can cause sepsis, a life&#x2d;threatening condition in which a patient&rsquo;s immune system overreacts to the infection. The body starts to attack itself, which can lead to tissue damage, organ failure, and death. Sepsis is very common &ndash; one out of every three&#8230;</p>
<p><a href="https://wyss.harvard.edu/technology/fcmbl-broad-spectrum-pathogen-capture-for-infectious-diseases/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/technology/fcmbl-broad-spectrum-pathogen-capture-for-infectious-diseases/</link>
          <title></title>
					<url>https://wyss-prod.imgix.net/app/uploads/2016/08/08120525/Staph-Beads-Gold.light_.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=258c7f8aa26c0fc6bd07e1a7efeaee26"/></url>
				</image>
        			</item>

		
			<item>
				<title>Renal reabsorption in living devices</title>
				<link>https://wyss.harvard.edu/news/renal-reabsorption-in-living-devices/</link>
        <pubDate>Mon, 04 Mar 2019 19:57:05 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Research Spotlights]]></category>
		<category><![CDATA[3D Bioprinting]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Harvard SEAS]]></category>
		<category><![CDATA[Jennifer A. Lewis]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=19603</guid>
                            <description>3D bioprinted, vascularized proximal tubules mimic the human kidney’s reabsorption functions</description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (CAMBRIDGE, Mass.) &mdash; Every day our kidneys tackle the daunting task of continuously cleaning our blood to prevent waste, salt and excess fluid from building up inside our bodies. To achieve this, the kidneys&rsquo; approximately one million filtration units (glomeruli) first remove both waste products and precious nutrients from the blood stream&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/renal-reabsorption-in-living-devices/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/renal-reabsorption-in-living-devices/</link>
          <title></title>
					<url>https://wyss-prod.imgix.net/app/uploads/2019/03/01093942/Vascularized-Proximal-Tubule.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=ea969d7d10ccbf17d03d8c28c8921076"/></url>
				</image>
        			</item>

		
			<item>
				<title>Sasan Jalili-Firoozinezhad honored with 2018 Lush Young Researcher award</title>
				<link>https://wyss.harvard.edu/news/sasan-jalili-firoozinezhad-honored-with-2018-lush-young-researcher-award/</link>
        <pubDate>Mon, 19 Nov 2018 18:58:29 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Awards]]></category>
		<category><![CDATA[Community]]></category>
		<category><![CDATA[Donald E. Ingber]]></category>
		<category><![CDATA[Gut-on-a-Chip]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=18449</guid>
                            <description>In a ceremony held in Berlin, Germany, Lush Foundation recognized potential of Wyss Institute’s human intestine chip for replacing animals in the study of radiation injury</description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON) &mdash; In a ceremony held in Berlin, Germany, Sasan Jalili&#x2d;Firoozinezhad received a Young Researcher Award from the Lush Foundation for his project modeling injuries that result from ionizing radiation on a human intestine&#x2d;on&#x2d;a&#x2d;chip (Intestine Chip). The Intestine Chip can be used to investigate potential countermeasure drugs that could be developed to treat and prevent&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/sasan-jalili-firoozinezhad-honored-with-2018-lush-young-researcher-award/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/sasan-jalili-firoozinezhad-honored-with-2018-lush-young-researcher-award/</link>
          <title>This photo shows Sasan Jallili Firoozinezhad (on the right) as one of the winners of the Young Researcher Americas category at the Lush Foundations 2018 award ceremony held in Berlin. Credit: Lush Foundation</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2018/11/19101021/Sasan-Firoozinezhad-Lush-Award-002.jpeg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=6304d2055f06c19b06e11f6059ffdea4"/></url>
				</image>
        			</item>

			</channel>
</rss>
